crohn's and glp 1 GLP-1 Use in Disease: Safety & IBD Considerations – PlexusDx Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
Noom makes it last.
Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access
This begs the question:
An anti-doping group is keeping a close eye on the use of these obesity and diabetes drugs in elite athletes
Clinical studies have shown that semaglutide can lead to significant weight loss when combined with a healthy lifestyle
Understanding this connection helps explain why these medications support metabolic health beyond weight loss alone
